Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.00    -0.50 (-0.14%)
Bid:
351.00
Ask:
356.00
Spread: 5.00 (1.425%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

6 Jun 2024 15:28

RNS Number : 4729R
Caledonia Investments PLC
06 June 2024
 

Caledonia Investments plc

 

Notification of transactions of persons discharging managerial responsibilities ("PDMR") or persons closely associated with them ("PCA")

 

Caledonia Investments plc ("Caledonia" or the "Company") has been notified pursuant to the requirements of the Market Abuse Regulation of the following transactions in its ordinary shares of 5p ("Shares") involving one of its directors, Mathew Masters.

 

On 4 June 2024, 16,603 Shares, as noted in the table below, were transferred to Mr Masters under the Caledonia Investments 2011 Performance Share Scheme ("2011 PSS"), the Caledonia Investments 2020 Performance Share Scheme ("2020 PSS") and the Caledonia Investments 2020 Deferred Bonus Plan ("DBP") at nil cost. All Shares were sourced from The Caledonia Investments plc Employee Share Trust ("EST"): 

 

Director

2011 PSS

2020 PSS

DBP

M S D Masters

7,792

4,218

4,593

 

On the same date, Mr Masters sold 7,826 Shares back to the EST to meet the tax liability due. All Shares were sold at 3552.5p per Share. He retained 8,777 Shares.

 

Following the above transactions, Mr Masters' total interests in Shares are as follows: 

 

Description

Number of Shares

Percentage of voting rights

Beneficial

67,153

0.12%

Non-beneficial

Nil

N/A

Performance share scheme awards

80,367

0.15%

Deferred bonus plan awards

6,849

0.01%

 

Further information required by the Market Abuse Regulation in relation to these transactions is set out in the appendix below.

 

Enquiries:

Richard Webster

Company Secretary

Tel: +44 20 7802 8080

 

6 June 2024

 

APPENDIX

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Mathew Simon Dexter Masters

2

 

Reason for the notification

 

a)

 

Position/status

 

Director/Chief Executive Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 5p shares

 

 

 

GB0001639920

 

b)

 

Nature of the transaction

 

 

1. Exercise of Caledonia Investments 2011 Performance Share Scheme ("2011 PSS") award

2. Exercise of Caledonia Investments 2020 Performance Share Scheme ("2020 PSS") award

3. Exercise of Caledonia Investments 2020 Deferred Bonus Plan ("DBP") award

4. Partial sale of shares to meet tax liability arising from 2011 PSS, 2020 PSS and DBP exercises

 

 

c)

 

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

 

Volume(s)

1.Exercise of 2011 PSS award

£0.00

 

7,792

2.Exercise of 2020 PSS award

£0.00

 

4,218

3.Exercise of DBP award

£0.00

 

4,593

4. Partial sale of shares arising from exercise of 2011 PSS, 2020 PSS and DBP awards

 

£35.525

7,826

 

 

 

d)

 

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

Aggregated volume

 

Aggregated price

1. Exercise of 2011 PSS, 2020 PSS and DBP awards

16,603

£0.00

2. Partial sale for tax

7,826

£35.525

 

 

e)

 

Date of the transaction

 

 

4 June 2024

f)

 

Place of the transaction

 

Exercise of 2011 PSS, 2020 PSS and DBP awards: London - outside a trading venue

 

Partial sale of shares: London Stock Exchange XLON

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBSGDLRDGDGSL
Date   Source Headline
5th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 202411:29 amRNSNet Asset Value(s)
1st Jul 20247:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTransaction in Own Shares
24th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20244:00 pmRNSAnnual Financial Report
7th Jun 20245:22 pmRNSDirector/PDMR Shareholding
6th Jun 20243:28 pmRNSDirector/PDMR Shareholding
6th Jun 20249:39 amRNSNet Asset Value(s)
30th May 20242:55 pmRNSDirector/PDMR Shareholding
21st May 20247:00 amRNSFinal Results
7th May 202410:40 amRNSNet Asset Value(s)
1st May 20247:00 amRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSNotice of annual results
22nd Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:30 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSUnaudited net asset value and portfolio update
2nd Apr 20247:01 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20243:19 pmRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202410:32 amRNSDirector Declaration
6th Mar 20242:33 pmRNSNet Asset Value(s)
20th Feb 20245:02 pmRNSDirector/PDMR Shareholding
7th Feb 20241:31 pmRNSNet Asset Value(s)
30th Jan 20243:58 pmRNSDirector/PDMR Shareholding
19th Jan 20244:30 pmRNS2023 AGM results update statement
18th Jan 202411:56 amRNSDisposal
8th Jan 20247:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20232:19 pmRNSNet Asset Value(s)
29th Nov 202311:49 amRNSDirector/PDMR Shareholding
27th Nov 20234:37 pmRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSHalf-year Report
14th Nov 20233:28 pmRNSNotice of Half-Year Results
7th Nov 20237:00 amRNSNet Asset Value(s)
6th Oct 20237:00 amRNSUnaudited net asset value and portfolio update
28th Sep 20233:28 pmRNSDirector/PDMR Shareholding
25th Sep 202310:58 amRNSDirector/PDMR Shareholding
20th Sep 20239:56 amRNSDirector/PDMR Shareholding
8th Sep 20234:34 pmRNSDirector/PDMR Shareholding
7th Sep 20231:50 pmRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSCaledonia signs agreement to sell 7IM
7th Aug 20237:00 amRNSNet Asset Value(s)
19th Jul 20235:53 pmRNSResult of AGM
7th Jul 202310:22 amRNSNet Asset Value and Portfolio Update
15th Jun 20234:01 pmRNSAnnual Financial Report
9th Jun 20235:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.